Franco-European Institute of Endometriosis long-term outcomes cohort
Cohort of the Franco-European Multidisciplinary Institute of Endometriosis
This cohort will follow women with confirmed pelvic endometriosis to see if different medical and surgical treatments lead to better long-term symptoms, quality of life, recurrence rates, and fertility outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 15000 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Clinique Tivoli Ducos Academic / other |
| Locations | 1 site (Bordeaux) |
| Trial ID | NCT07243587 on ClinicalTrials.gov |
What this trial studies
This is a prospective, observational, single-center cohort conducted at the Endometriosis Center of Clinique Tivoli-Ducos in Bordeaux, France. Women with histologically or radiologically confirmed pelvic or deep endometriosis are enrolled after consent and complete standardized questionnaires at baseline and at 1, 3, 5, 7, and 10 years, with data collected via the secure NO ENDO online platform or in clinic. The study records treatment choices (medical and surgical), symptom scores, quality-of-life measures, recurrence, and fertility outcomes without altering patient care. The goal is to provide long-term outcome data that are currently scarce in endometriosis research.
Who should consider this trial
Good fit: Women aged over 18 with histologically or radiologically confirmed pelvic or deep endometriosis who are seen or operated on at Clinique Tivoli-Ducos and who are affiliated with the social security system are ideal candidates.
Not a fit: People without confirmed endometriosis, those who refuse participation, those under guardianship or deprived of liberty, and patients unwilling or unable to engage in long-term follow-up are unlikely to benefit from this cohort.
Why it matters
Potential benefit: If successful, this cohort could provide clearer long-term outcome data to help patients and clinicians choose treatments and improve counseling about risks, symptom control, and fertility expectations.
How similar studies have performed: Previous randomized trials and retrospective series have reported short-term outcomes for various treatments, but large prospective long-term cohorts with follow-up beyond a few years are scarce, so this long-term approach addresses a notable gap.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women aged \>18 years * Women with histologically or radiologically confirmed deep endometriosis (and/or) infiltrating the colon and/or rectum * Women affiliated with the social security system Exclusion Criteria: * Refusal to participate * Patients under guardianship or curatorship, or deprived of liberty
Where this trial is running
Bordeaux
- Clinique Tivoli Ducos — Bordeaux, France (Recruiting)
Study contacts
- Study coordinator: Horace ROMAN
- Email: horace.roman@ifemendo.fr
- Phone: 0556116000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.